These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 25490392)
1. REGγ regulates ERα degradation via ubiquitin-proteasome pathway in breast cancer. Chai F; Liang Y; Bi J; Chen L; Zhang F; Cui Y; Jiang J Biochem Biophys Res Commun; 2015 Jan; 456(1):534-40. PubMed ID: 25490392 [TBL] [Abstract][Full Text] [Related]
2. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome. Li X; Lonard DM; Jung SY; Malovannaya A; Feng Q; Qin J; Tsai SY; Tsai MJ; O'Malley BW Cell; 2006 Jan; 124(2):381-92. PubMed ID: 16439211 [TBL] [Abstract][Full Text] [Related]
3. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Li X; Amazit L; Long W; Lonard DM; Monaco JJ; O'Malley BW Mol Cell; 2007 Jun; 26(6):831-42. PubMed ID: 17588518 [TBL] [Abstract][Full Text] [Related]
4. Silencing CDR1as enhances the sensitivity of breast cancer cells to drug resistance by acting as a miR-7 sponge to down-regulate REGγ. Yang W; Yang X; Wang X; Gu J; Zhou D; Wang Y; Yin B; Guo J; Zhou M J Cell Mol Med; 2019 Aug; 23(8):4921-4932. PubMed ID: 31245927 [TBL] [Abstract][Full Text] [Related]
5. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen. Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770 [TBL] [Abstract][Full Text] [Related]
6. REG gamma: a potential marker in breast cancer and effect on cell cycle and proliferation of breast cancer cell. Wang X; Tu S; Tan J; Tian T; Ran L; Rodier JF; Ren G Med Oncol; 2011 Mar; 28(1):31-41. PubMed ID: 20467919 [TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Chen X; Barton LF; Chi Y; Clurman BE; Roberts JM Mol Cell; 2007 Jun; 26(6):843-52. PubMed ID: 17588519 [TBL] [Abstract][Full Text] [Related]
8. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells. Fan M; Bigsby RM; Nephew KP Mol Endocrinol; 2003 Mar; 17(3):356-65. PubMed ID: 12554766 [TBL] [Abstract][Full Text] [Related]
9. REGgamma proteasome mediates degradation of the ubiquitin ligase Smurf1. Nie J; Wu M; Wang J; Xing G; He F; Zhang L FEBS Lett; 2010 Jul; 584(14):3021-7. PubMed ID: 20580715 [TBL] [Abstract][Full Text] [Related]
10. Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B. Prenzel T; Begus-Nahrmann Y; Kramer F; Hennion M; Hsu C; Gorsler T; Hintermair C; Eick D; Kremmer E; Simons M; Beissbarth T; Johnsen SA Cancer Res; 2011 Sep; 71(17):5739-53. PubMed ID: 21862633 [TBL] [Abstract][Full Text] [Related]
11. The REGγ proteasome regulates hepatic lipid metabolism through inhibition of autophagy. Dong S; Jia C; Zhang S; Fan G; Li Y; Shan P; Sun L; Xiao W; Li L; Zheng Y; Liu J; Wei H; Hu C; Zhang W; Chin YE; Zhai Q; Li Q; Liu J; Jia F; Mo Q; Edwards DP; Huang S; Chan L; O'Malley BW; Li X; Wang C Cell Metab; 2013 Sep; 18(3):380-91. PubMed ID: 24011073 [TBL] [Abstract][Full Text] [Related]
12. High expression of REGγ is associated with metastasis and poor prognosis of patients with breast cancer. Chai F; Liang Y; Bi J; Chen L; Zhang F; Cui Y; Bian X; Jiang J Int J Clin Exp Pathol; 2014; 7(11):7834-43. PubMed ID: 25550823 [TBL] [Abstract][Full Text] [Related]
13. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha. Fan M; Park A; Nephew KP Mol Endocrinol; 2005 Dec; 19(12):2901-14. PubMed ID: 16037132 [TBL] [Abstract][Full Text] [Related]
14. Regulation of Life & Death by REGγ. Funderburk KE; Kang J; Li HJ Cells; 2022 Jul; 11(15):. PubMed ID: 35892577 [TBL] [Abstract][Full Text] [Related]
15. ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ-proteasome pathway. Cai Q; Zhu H; Dai Y; Zhou Q; Zhang Q; Zhu Q Mol Carcinog; 2024 Oct; 63(10):1874-1891. PubMed ID: 38888205 [TBL] [Abstract][Full Text] [Related]
16. REGγ deficiency suppresses tumor progression via stabilizing CK1ε in renal cell carcinoma. Chen S; Wang Q; Wang L; Chen H; Gao X; Gong D; Ma J; Kubra S; Yao X; Li X; Li L; Zhai W; Zheng J Cell Death Dis; 2018 May; 9(6):627. PubMed ID: 29795381 [TBL] [Abstract][Full Text] [Related]
17. REGgamma, a proteasome activator and beyond? Mao I; Liu J; Li X; Luo H Cell Mol Life Sci; 2008 Dec; 65(24):3971-80. PubMed ID: 18679578 [TBL] [Abstract][Full Text] [Related]
18. Differential regulation of the REGγ-proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells. Ali A; Wang Z; Fu J; Ji L; Liu J; Li L; Wang H; Chen J; Caulin C; Myers JN; Zhang P; Xiao J; Zhang B; Li X Nat Commun; 2013; 4():2667. PubMed ID: 24157709 [TBL] [Abstract][Full Text] [Related]
19. miR-7-5p suppresses cell proliferation and induces apoptosis of breast cancer cells mainly by targeting REGγ. Shi Y; Luo X; Li P; Tan J; Wang X; Xiang T; Ren G Cancer Lett; 2015 Mar; 358(1):27-36. PubMed ID: 25511742 [TBL] [Abstract][Full Text] [Related]
20. Regulation of energy homeostasis by the ubiquitin-independent REGγ proteasome. Sun L; Fan G; Shan P; Qiu X; Dong S; Liao L; Yu C; Wang T; Gu X; Li Q; Song X; Cao L; Li X; Cui Y; Zhang S; Wang C Nat Commun; 2016 Aug; 7():12497. PubMed ID: 27511885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]